Table 3: Studied patients’ and controls’ characteristics.

PatientsControls 𝑃

Number1630
Males1112
Mean age 71 (6)72 (5)Ns
Diabetes mellitus35Ns
Hypertension812Ns
Coronary heart disease59Ns
Heart failure12Ns
Renal failure13 Ns
Atrial fibrillation 24Ns
Stroke/TIA45Ns
CODP 24Ns
Neoplasia12Ns
LDL-cholesterol mg/dl112131Ns
ACEi/ARB14210.04
β blockers612Ns
CC blockers511Ns
Diuretics411Ns
α blockers24Ns
OH5 (31%)3 (10%)<0.01
no. episodes of syncope 435<0.01
no. episodes of presyncope10211<0.01
Syncope and presyncope/
year from PM implant
1.30.16<0.01
Injury121<0.01